In parallel, MerryLife is exploring the potential relevance of TML-6 in Parkinson's disease, where similar pathological mechanisms contribute to disease progression. The company will present ...
MerryLife Biomedical Inc., a clinical-stage biotechnology company focused on neurodegenerative diseases, today announced positive Phase 1 results for TML-6 ...
Sanofi's rilzabrutinib designated breakthrough therapy in the US and orphan drug in Japan for the treatment of warm autoimmune hemolytic anemia Rilzabrutinib is the first and only investigational BTKi ...
NMD Pharma is accelerating ignaseclant’s clinical development in CMT alongside multiple near-term clinical catalysts across its neuromuscular pipeline, with Phase 2 studies in spinal muscular atrophy ...
CS014 is a novel, orally administered HDAC inhibitor with potential to address underlying disease mechanisms in severe cardiopulmonary diseases. With a completed Phase I study and a broadened ...
In this phase 2a study, researchers aimed to determine whether donor fecal microbiota transplantation improved survival in mRCC patients receiving immunotherapy.
Researchers at the Institute for Molecular Science (NINS, Japan) and SOKENDAI have demonstrated a more than 2000% voltage-induced enhancement of near-field nonlinear optical responses. To achieve this ...
A wide of array of advanced controllers arrived in 2025, marked by high integration and enhanced intelligence in solutions ...
Today's most powerful computers hit a wall when tackling certain problems, from designing new drugs to cracking encryption ...
See what moon phase it is tonight and find out when you can see the rest of the moon phases for 2026. When you purchase through links on our site, we may earn an affiliate commission. Here’s how it ...
Newron Pharmaceuticals notes new publication highlighting clinically meaningful benefits of evenamide as an adjunctive treatment in schizophrenia ...
Adequate and healthy nutrition is important during the postpartum time to support wound healing, hormone balance, energy, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results